Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-043727)

Filing Details

Accession Number:: 0001181431-13-043727
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-08 13:00:00
Reporting Period:: 2013-08-05

Filing Date:: 2013-08-08
Accepted Time:: 2013-08-08 17:14:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
906709	Nektar Therapeutics	NKTR	Pharmaceutical Preparations (2834)	943134940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229877	A Christopher Kuebler	C/O Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco CA 94158		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-08-05	12,500	$11.41	32,500	No	4	M	Direct
Common Stock	Disposition	2013-08-05	12,500	$12.41	20,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2013-08-05	12,500	$0.00	12,500	$11.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-09-03	No	4	M	Direct

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan and the stock options exercised were scheduled to expire within 30 days of the date of this transaction.
This stock option vests in equal montly installments over one year commencing on September 4, 2003.